Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. Five out of 10 post-mortem brains of patients ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Parkinson’s disease, the second most common neurodegenerative disorder globally, is often associated with vocal impairments, ...

These findings highlight the significance of rearing behavior and behavioral lateralization as potential behavioral markers ...